Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eng King Tan

Showing results (331-340 of 445) with videos related to

Pageof 45
Sort By:
Human Molecular Genetics|June 29, 2022
Mutant VPS35-D620N induces motor dysfunction and impairs DAT-mediated dopamine recycling pathwayYi Huang, Heng Huang, Leping Zhou, et al.
Molecular Therapy. Nucleic Acids|September 23, 2024
Targeting heterozygous dominant negative variant of <i>KCNA2</i> using Gapmer ASO for the treatment of drug-resistant epilepsyHua Huang, Dong Rui Ma, Derrick Wei Shih Chan, et al.
Neurology|April 24, 2025
Investigating Plasma Metabolomics and Gut Microbiota Changes Associated With Parkinson Disease: A Focus on Caffeine MetabolismChieh-Chang Chen, Jian-Ying Chiu, Ai Huey Tan, et al.
Plos Genetics|April 28, 2010
Deletion of the WD40 domain of LRRK2 in Zebrafish causes Parkinsonism-like loss of neurons and locomotive defectDonglai Sheng, Dianbo Qu, Ken Hon Hung Kwok, et al.
Parkinson'S Disease|May 16, 2015
Association Analysis of COQ2 Variant in Dementia and Essential TremorYin Xia Chao, Ebonne Yu Lin Ng, Huihua Li, et al.
Journal of Neurology|June 14, 2026
Combination therapy of levodopa with safinamide is more effective than with rasagiline and zonisamide in Asian Parkinson's disease patients with motor fluctuations: a systematic review and network meta-analysis of randomized controlled trialsYu Wang, Xi-Xi Wang, Bing-Ji Yuan, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 20, 2026
Update on Medical Treatments for Essential Tremor: An International Parkinson and Movement Disorder Society Evidence-Based Medicine ReviewDeepa Dash, Verónica Bruno, Petra Schwingenschuh, et al.
Cellular and Molecular Life Sciences : CMLS|November 21, 2022
The role of tyrosine hydroxylase-dopamine pathway in Parkinson's disease pathogenesisZhi Dong Zhou, Wuan Ting Saw, Patrick Ghim Hoe Ho, et al.
Science Signaling|July 20, 2017
Phosphorylation of amyloid precursor protein by mutant LRRK2 promotes AICD activity and neurotoxicity in Parkinson's diseaseZhong-Can Chen, Wei Zhang, Ling-Ling Chua, et al.
International Journal of Molecular Sciences|May 7, 2025
Environmental Factors Exacerbate Parkinsonian Phenotypes in an Asian-Specific Knock-In LRRK2 Risk Variant in MiceZoë Bichler, Sarivin Vanan, Zhiwei Zhang, et al.
Pageof 45

Showing results (331-340 of 445) with videos related to

Sort By:
Pageof 45
Human Molecular Genetics|June 29, 2022
Mutant VPS35-D620N induces motor dysfunction and impairs DAT-mediated dopamine recycling pathwayYi Huang, Heng Huang, Leping Zhou, et al.
Molecular Therapy. Nucleic Acids|September 23, 2024
Targeting heterozygous dominant negative variant of <i>KCNA2</i> using Gapmer ASO for the treatment of drug-resistant epilepsyHua Huang, Dong Rui Ma, Derrick Wei Shih Chan, et al.
Neurology|April 24, 2025
Investigating Plasma Metabolomics and Gut Microbiota Changes Associated With Parkinson Disease: A Focus on Caffeine MetabolismChieh-Chang Chen, Jian-Ying Chiu, Ai Huey Tan, et al.
Plos Genetics|April 28, 2010
Deletion of the WD40 domain of LRRK2 in Zebrafish causes Parkinsonism-like loss of neurons and locomotive defectDonglai Sheng, Dianbo Qu, Ken Hon Hung Kwok, et al.
Parkinson'S Disease|May 16, 2015
Association Analysis of COQ2 Variant in Dementia and Essential TremorYin Xia Chao, Ebonne Yu Lin Ng, Huihua Li, et al.
Journal of Neurology|June 14, 2026
Combination therapy of levodopa with safinamide is more effective than with rasagiline and zonisamide in Asian Parkinson's disease patients with motor fluctuations: a systematic review and network meta-analysis of randomized controlled trialsYu Wang, Xi-Xi Wang, Bing-Ji Yuan, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 20, 2026
Update on Medical Treatments for Essential Tremor: An International Parkinson and Movement Disorder Society Evidence-Based Medicine ReviewDeepa Dash, Verónica Bruno, Petra Schwingenschuh, et al.
Cellular and Molecular Life Sciences : CMLS|November 21, 2022
The role of tyrosine hydroxylase-dopamine pathway in Parkinson's disease pathogenesisZhi Dong Zhou, Wuan Ting Saw, Patrick Ghim Hoe Ho, et al.
Science Signaling|July 20, 2017
Phosphorylation of amyloid precursor protein by mutant LRRK2 promotes AICD activity and neurotoxicity in Parkinson's diseaseZhong-Can Chen, Wei Zhang, Ling-Ling Chua, et al.
International Journal of Molecular Sciences|May 7, 2025
Environmental Factors Exacerbate Parkinsonian Phenotypes in an Asian-Specific Knock-In LRRK2 Risk Variant in MiceZoë Bichler, Sarivin Vanan, Zhiwei Zhang, et al.
Pageof 45